Published in Biochim Biophys Acta on April 12, 1977
Phosphatidylinositol metabolism in rat hepatocytes stimulated by glycogenolytic hormones. Effects of angiotensin, vasopressin, adrenaline, ionophore A23187 and calcium-ion deprivation. Biochem J (1979) 1.55
Glycogen-storage disease in rats, a genetically determined deficiency of liver phosphorylase kinase. Biochem J (1980) 1.41
Insulin inhibition of alpha-adrenergic actions in liver. Biochem J (1981) 1.04
Control of glycogen phosphorylase interconversion by phorbol esters, diacylglycerols, Ca2+ and hormones in isolated rat hepatocytes. Biochem J (1985) 1.02
The activation of Na+-dependent efflux of Ca2+ from liver mitochondria by glucagon and beta-adrenergic agonists. Biochem J (1983) 1.01
Mechanism of activation of glycogen phosphorylase by fructose in the liver. Stimulation of phosphorylase kinase related to the consumption of adenosine triphosphate. Biochem J (1979) 0.96
Rapid activation of glycogen phosphorylase by steroid hormones in cultured rat hepatocytes. Biochem J (1989) 0.83
Altered liver glycogen metabolism in fed genetically obese mice. Biochem J (1983) 0.78
Unsaturated fatty acids activate glycogen phosphorylase in cultured rat hepatocytes. Biochem J (1991) 0.75
Gbetagamma-mediated regulation of Golgi organization is through the direct activation of protein kinase D. Cell (1999) 2.67
Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett (1992) 2.52
On the role of calcium as second messenger in liver for the hormonally induced activation of glycogen phosphorylase. Biochim Biophys Acta (1977) 2.46
The sequential inactivation of glycogen phosphorylase and activation of glycogen synthetase in liver after the administration of glucose to mice and rats. The mechanism of the hepatic threshold to glucose. Eur J Biochem (1974) 2.10
Specific features of glycogen metabolism in the liver. Biochem J (1998) 1.99
Inactivation of glycogen synthase kinase-3 by epidermal growth factor is mediated by mitogen-activated protein kinase/p90 ribosomal protein S6 kinase signaling pathway in NIH/3T3 cells. J Biol Chem (1995) 1.95
(3H)-vasopressin binding to isolated rat hepatocytes and liver membranes: regulation by GTP and relation to glycogen phosphorylase activation. J Recept Res (1980) 1.76
The mechanism by which epidermal growth factor inhibits glycogen synthase kinase 3 in A431 cells. Biochem J (1994) 1.75
The activation of liver phosphorylase b kinase by glucagon. FEBS Lett (1976) 1.31
ATP x Mg-dependent protein phosphatase from rabbit skeletal muscle. II. Purification of the activating factor and its characterization as a bifunctional protein also displaying synthase kinase activity. J Biol Chem (1980) 1.31
Regulation of protein kinase D by multisite phosphorylation. Identification of phosphorylation sites by mass spectrometry and characterization by site-directed mutagenesis. J Biol Chem (2000) 1.27
Heterologous desensitization of the cyclic AMP-independent glycogenolytic response in rat liver cells. Biochem J (1981) 1.26
The control of glycogen synthesis in the liver. Adv Enzyme Regul (1970) 1.25
The activation of liver glycogen phosphorylase by vasopressin. FEBS Lett (1975) 1.18
Multiple and cooperative phosphorylation events regulate the CREM activator function. EMBO J (1993) 1.17
Characterization of the liver P2-purinoceptor involved in the activation of glycogen phosphorylase. Biochem J (1986) 1.15
The effect of glucose and of a treatment by glucocorticoids on the activation in vitro of liver glycogen synthetase. Eur J Biochem (1970) 1.15
The stimulation of glycogen synthesis and of glycogen synthetase in the liver by the administration of glucose. Eur J Biochem (1967) 1.15
The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin. J Biol Chem (1999) 1.14
Purification, properties, and substrate specificities of phosphoprotein phosphatase(s) from rabbit liver. J Biol Chem (1976) 1.14
Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells. Oncogene (2007) 1.14
The nature of the hepatic receptors involved in vasopressin-induced glycogenolysis. Biochim Biophys Acta (1979) 1.13
The activation of liver glycogen phosphorylase by angiotensin II. FEBS Lett (1976) 1.13
P2-purinergic control of liver glycogenolysis. Biochem J (1985) 1.13
Deficiency in apoptotic effectors Bax and Bak reveals an autophagic cell death pathway initiated by photodamage to the endoplasmic reticulum. Autophagy (2006) 1.11
Neonatal neuronal overexpression of glycogen synthase kinase-3 beta reduces brain size in transgenic mice. Neuroscience (2002) 1.09
Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis. Involvement of cytochrome c and procaspase-3 activation in the mechanism of apoptosis. FEBS Lett (1998) 1.08
The ATPMg-dependent phosphatase is present in mammalian vascular smooth muscle. Biochem Biophys Res Commun (1982) 1.08
Phosphorylation of yeast plasma membrane H+-ATPase by casein kinase I. J Biol Chem (1996) 1.06
Demonstration of a glycogen/glucose 1-phosphate cycle in hepatocytes from fasted rats. Selective inactivation of phosphorylase by 2-deoxy-2-fluoro-alpha-D-glucopyranosyl fluoride. J Biol Chem (1995) 1.06
The liver angiotensin receptor involved in the activation of glycogen phosphorylase. Biochem J (1982) 1.05
A simplified procedure for the purification of the protein phosphatase modulator (inhibitor-2) from rabbit skeletal muscle. FEBS Lett (1981) 1.03
The effect of glucose and of a treatment by glucocorticoids on the inactivation in vitro of liver glycogen phosphorylase. Eur J Biochem (1970) 1.03
Characterization of the biological effects of 2-methylthio-ATP on rat hepatocytes: clear-cut differences with ATP. Br J Pharmacol (1991) 1.02
Extracellular ATP and UTP exert similar effects on rat isolated hepatocytes. Br J Pharmacol (1992) 1.02
Casein kinase-1 phosphorylates the p75 tumor necrosis factor receptor and negatively regulates tumor necrosis factor signaling for apoptosis. J Biol Chem (1995) 1.01
Vasopressin and angiotensin control the activity of liver phosphodiesterase. Biochem J (1984) 1.01
ATP x Mg-dependent protein phosphatase from rabbit skeletal muscle. I. Purification of the enzyme and its regulation by the interaction with an activating protein factor. J Biol Chem (1980) 1.01
Characterization of purinoceptors present on human liver plasma membranes. FEBS Lett (1989) 1.01
Differential stimulation of ERK and JNK activities by ultraviolet B irradiation and epidermal growth factor in human keratinocytes. J Invest Dermatol (1997) 1.01
p38 mitogen-activated protein kinase regulates a novel, caspase-independent pathway for the mitochondrial cytochrome c release in ultraviolet B radiation-induced apoptosis. J Biol Chem (2000) 1.01
Nuclear and subnuclear targeting sequences of the protein phosphatase-1 regulator NIPP1. J Cell Sci (2000) 1.00
An assessment of the importance of intralysosomal and of alpha-amylolytic glycogenolysis in the liver of normal rats and of rats with a glycogen-storage disease. Eur J Biochem (1985) 1.00
Regulation of ATP-Mg-dependent protein phosphatase. Curr Top Cell Regul (1984) 0.99
The control of glycogen metabolism in the liver. FEBS Lett (1970) 0.98
Inhibition of the Mg(II).ATP-dependent phosphoprotein phosphatase by the regulatory subunit of cAMP-dependent protein kinase. Proc Natl Acad Sci U S A (1985) 0.98
Platelet-derived growth factor stimulates protein kinase D through the activation of phospholipase Cgamma and protein kinase C. J Biol Chem (1998) 0.96
A synthetic peptide substrate specific for casein kinase I. FEBS Lett (1989) 0.95
Characterization of the effects of adenosine 5'-[beta-thio]-diphosphate in rat liver. Br J Pharmacol (1993) 0.95
A specific immunoprecipitation assay for the protein kinase FA/glycogen synthase kinase 3. Anal Biochem (1993) 0.95
Phosphorylation of the phosphatase modulator subunit (inhibitor-2) by casein kinase-1. Identification of the phosphorylation sites. FEBS Lett (1992) 0.95
Fluorescence studies on the interaction of inhibitor 2 and okadaic acid with the catalytic subunit of type 1 phosphoprotein phosphatases. Biochemistry (1991) 0.94
Modulation of basal hepatic glycogenolysis by nitric oxide. Hepatology (1996) 0.92
Antifreeze glycoproteins from the blood of an antarctic fish. The structure of the proline-containing glycopeptides. J Biol Chem (1978) 0.91
Photosensitized inhibition of growth factor-regulated protein kinases by hypericin. Biochem Pharmacol (1995) 0.91
On the mechanism of activation of the ATP X Mg(II)-dependent phosphoprotein phosphatase by kinase FA. J Biol Chem (1984) 0.90
Characterization of glycogen-synthase phosphatase and phosphorylase phosphatase in subcellular liver fractions. Biochim Biophys Acta (1988) 0.90
Characteristics of the desensitization and resensitization of the cyclic AMP-independent glycogenolytic response in rat liver cells. Biochem J (1982) 0.90
The stimulation of glycogen synthesis andof glycogen synthetase in the liver by glucocorticoids. Eur J Biochem (1967) 0.89
Interleukin-8 activates microtubule-associated protein 2 kinase (ERK1) in human neutrophils. Mol Cell Biochem (1993) 0.88
On the role of calcium ions in the regulation of glycogenolysis in mouse brain cortical slices. J Neurochem (1982) 0.87
Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model. Int J Cancer (2001) 0.87
Protein inhibitors of dog-liver phosphorylase phosphatase dependent on and independent of protein kinase. Eur J Biochem (1978) 0.86
Control of glycogen synthesis in cultured human muscle cells. J Biol Chem (1999) 0.86
Identification of inhibitor-2 as the ATP-mg-dependent protein phosphatase modulator. J Biol Chem (1981) 0.86
Conversion of active protein phosphatase to the ATP-Mg-dependent enzyme form by inhibitor-2. FEBS Lett (1981) 0.86
Proceedings: Is calcium the second messenger in liver for cyclic AMP-independent glycogenolytic hormones? Arch Int Physiol Biochim (1976) 0.84
Rabbit skeletal muscle protein phosphatase(s). Identity of phosphorylase and synthase phosphatase and interconversion to the ATP-Mg-dependent enzyme form. J Biol Chem (1981) 0.84
Apoptotic and anti-apoptotic signaling pathways induced by photodynamic therapy with hypericin. Adv Enzyme Regul (2000) 0.83
Rapid stimulation of Ser/Thr protein kinases following treatment of Swiss 3T3 cells with bombesin. Involvement of casein kinase-2 in the signaling pathway of bombesin. J Biol Chem (1992) 0.83
The level of the glycogen targetting regulatory subunit R5 of protein phosphatase 1 is decreased in the livers of insulin-dependent diabetic rats and starved rats. Biochem J (2001) 0.83
Characterization of different forms of kinase FA from rabbit skeletal muscle. Adv Enzyme Regul (1983) 0.83
Differences in liver glycogen-synthase phosphatase activity in rodents with spontaneous insulin-dependent and non-insulin-dependent diabetes. Diabetologia (1988) 0.82
Lack of V1 vasopressin receptors in rabbit hepatocytes. Biochem J (1989) 0.82
Proceedings: Angiotensin exerts a direct glycogenolytic action on the liver. Arch Int Physiol Biochim (1976) 0.81
Periportal and perivenous hepatocytes respond equally to glycogenolytic agonists. FEBS Lett (1988) 0.81
Early responses in mitogenic signaling, bombesin induced protein phosphorylations in Swiss 3T3 cells. Adv Enzyme Regul (1993) 0.81
Elucidation of the tumoritropic principle of hypericin. Br J Cancer (2005) 0.81
Insulin action in cultured human myoblasts: contribution of different signalling pathways to regulation of glycogen synthesis. Biochem J (1996) 0.81
Phosphorylation of the modulator protein of the ATP, Mg-dependent protein phosphatase by casein kinase TS. Reversal by PCS phosphatases and control by distinct phosphorylation site(s). FEBS Lett (1986) 0.81
The somatostatin analogue TT-232 induces apoptosis in A431 cells: sustained activation of stress-activated kinases and inhibition of signalling to extracellular signal-regulated kinases. Cell Signal (2001) 0.81
The alpha-adrenergic control of rabbit liver glycogenolysis. Biochem Pharmacol (1979) 0.81